Literature DB >> 29891520

NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018.

Manisha H Shah, Whitney S Goldner, Thorvardur R Halfdanarson, Emily Bergsland, Jordan D Berlin, Daniel Halperin, Jennifer Chan, Matthew H Kulke, Al B Benson, Lawrence S Blaszkowsky, Jennifer Eads, Paul F Engstrom, Paul Fanta, Thomas Giordano, Jin He, Martin J Heslin, Gregory P Kalemkerian, Fouad Kandeel, Sajid A Khan, Wajih Zaheer Kidwai, Pamela L Kunz, Boris W Kuvshinoff, Christopher Lieu, Venu G Pillarisetty, Leonard Saltz, Julie Ann Sosa, Jonathan R Strosberg, Craig A Sussman, Nikolaos A Trikalinos, Nataliya A Uboha, Jonathan Whisenant, Terence Wong, James C Yao, Jennifer L Burns, Ndiya Ogba, Griselda Zuccarino-Catania.   

Abstract

The NCCN Guidelines for Neuroendocrine and Adrenal Tumors provide recommendations for the management of adult patients with neuroendocrine tumors (NETs), adrenal gland tumors, pheochromocytomas, and paragangliomas. Management of NETs relies heavily on the site of the primary NET. These NCCN Guidelines Insights summarize the management options and the 2018 updates to the guidelines for locoregional advanced disease, and/or distant metastasis originating from gastrointestinal tract, bronchopulmonary, and thymus primary NETs.
Copyright © 2018 by the National Comprehensive Cancer Network.

Entities:  

Mesh:

Year:  2018        PMID: 29891520     DOI: 10.6004/jnccn.2018.0056

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  102 in total

1.  Metastatic retroperitoneal paraganglioma: Case report and review of the literature.

Authors:  Alexandra L Tabakin; Michael A Weintraub; Kushan D Radadia; Cristo G Salazar; Evita Sadimin; Eric A Singer
Journal:  Clin Oncol (Belmont)       Date:  2019-03-08

2.  Small Bowel Neuroendocrine Tumors.

Authors:  Catherine G Tran; Scott K Sherman; James R Howe
Journal:  Curr Probl Surg       Date:  2020-05-15       Impact factor: 1.909

3.  Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database.

Authors:  Hussein A Assi; Sarbajit Mukherjee; Pamela L Kunz; Michael Machiorlatti; Sara Vesely; Vipul Pareek; Hassan Hatoum
Journal:  Oncologist       Date:  2019-10-02

4.  Capecitabine and Temozolomide in Advanced Lung Neuroendocrine Neoplasms.

Authors:  Taymeyah Al-Toubah; Brian Morse; Jonathan Strosberg
Journal:  Oncologist       Date:  2019-08-27

5.  Real-World Treatment Patterns and Clinical Outcomes in Advanced Gastrointestinal Neuroendocrine Tumors (GI NET): A Multicenter Retrospective Chart Review Study.

Authors:  Matthew H Kulke; Al B Benson; Arvind Dasari; Lynn Huynh; Beilei Cai; Todor Totev; Nina Roesner; Mei Sheng Duh; Maureen P Neary; Victoria E Maurer; Brandon E Shih; Cecile G Dagohoy; Jennifer Chan; Emily K Bergsland
Journal:  Oncologist       Date:  2019-01-03

6.  Predictive value of the Ki67 index for lymph node metastasis of small non-functioning pancreatic neuroendocrine neoplasms.

Authors:  Toshihiko Masui; Asahi Sato; Kenzo Nakano; Yuichiro Uchida; Akitada Yogo; Takayuki Anazawa; Kazuyuki Nagai; Yoshiya Kawaguchi; Kyoichi Takaori; Shinji Uemoto
Journal:  Surg Today       Date:  2019-03-05       Impact factor: 2.549

7.  Prospective comparison of whole-body MRI with diffusion-weighted and conventional imaging for the follow-up of neuroendocrine tumors.

Authors:  Maximilien Minon; Clothilde Soriano; David Morland; Thomas Walter; Côme Lepage; Antoine Tabarin; Mathilde Deblock; Pascal Rousset; Coralie Barbe; Christine Hoeffel; Guillaume Cadiot
Journal:  Endocrine       Date:  2019-09-28       Impact factor: 3.633

8.  Sunitinib-Loaded Chondroitin Sulfate Hydrogels as a Novel Drug-Delivery Mechanism for the Treatment of Pancreatic Neuroendocrine Tumors.

Authors:  Xavier M Keutgen; Kimberly J Ornell; Alyx Vogle; Olga Lakiza; Jelani Williams; Paul Miller; Katelyn S Mistretta; Namrata Setia; Ralph R Weichselbaum; Jeannine M Coburn
Journal:  Ann Surg Oncol       Date:  2021-06-05       Impact factor: 5.344

9.  Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms?

Authors:  D Mark Pritchard; Christos Toumpanakis; Klaire Exarchou; Lukasz Kamieniarz; Marina Tsoli; Alexandra Victor; Kira Oleinikov; Mohid S Khan; Raj Srirajaskanthan; Dalvinder Mandair; Simona Grozinsky-Glasberg; Gregory Kaltsas; Nathan Howes
Journal:  Endocrine       Date:  2021-06-12       Impact factor: 3.633

Review 10.  Targeted Therapies in the Management of Well-Differentiated Digestive and Lung Neuroendocrine Neoplasms.

Authors:  Namrata Vijayvergia; Arvind Dasari
Journal:  Curr Treat Options Oncol       Date:  2020-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.